Clinical Trial Update: A Study of Glofitamab-based Treatment in People With Diffuse Large B-cell Lymphoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a glofitamab-based treatment in people with diffuse large B-cell lymphoma and high-grade B-cell lymphoma, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diffuse Large B-cell Lymphoma
• High-grade B-cell Lymphoma

Drugs mentioned

• Glofitamab (glofitamab)

Snippet

Sponsor: Memorial Sloan Kettering Cancer Center | Conditions: Diffuse Large B Cell Lymphoma (DLBCL), High Grade B Cell Lymphoma | Phase 2 | Status: RECRUITING